India’s drug regulator has suspended the approval granted to Entod Pharmaceutical Ltd. to manufacture PresVu eye drops, citing the company’s unapproved claims that the drops reduce dependency on reading glasses. The regulator raised concerns about the safety of the eye drops and their over-the-counter use, as they were approved as a prescription drug. Entod Pharmaceuticals has disputed the suspension and plans to challenge the order in court.